Disclosed are catalyst systems comprising the reaction product of at least the following: A) a procatalyst; and B) at least one cocatalyst structure selected from the following i) through iii): i) at least one cocatalyst comprising an anion having Structure 1 as shown below: ##STR00001##  as described herein; or ii) at least one cocatalyst comprising an anion having Structure 2 as shown below: ##STR00002##  as described herein; or iii) a combination of i and ii.

Disclosed are catalyst systems comprising the reaction product of at least the following: A) a procatalyst; and B) at least one cocatalyst structure selected from the following i) through iii): i) at least one cocatalyst comprising an anion having Structure 1 as shown below: ##STR00001##  as described herein; or ii) at least one cocatalyst comprising an anion having Structure 2 as shown below: ##STR00002##  as described herein; or iii) a combination of i and ii.

Borylated Amino Acid (“BAA”) compositions and methods of making BAAs are disclosed herein. Consequently, the BAAs can be administered to patients as a Neutron Capture Agent and provide a method of treating cancer, immunological disorders and other disease by utilizing a Neutron Capture Therapy modality.

Borylated Amino Acid (“BAA”) compositions and methods of making BAAs are disclosed herein. Consequently, the BAAs can be administered to patients as a Neutron Capture Agent and provide a method of treating cancer, immunological disorders and other disease by utilizing a Neutron Capture Therapy modality.

The present invention pertains to a method for producing a copolymer of ethylene and an allyl monomer having a polar group represented by general formula (1), or a copolymer of ethylene, an allyl monomer having a polar group represented by general formula (1), and other monomers, wherein the copolymer is produced in the presence of a boron compound having a boron-hydrogen bond or a boron-carbon bond (for example, a compound represented by general formula (2)) by using a metal complex represented by general formula (C1) as a polymerization catalyst (the symbols in the formulas are as described in the description). According to the present invention, a copolymer of ethylene and an allyl monomer can be efficiently produced with high catalytic activity, wherein the copolymer has a polar group and can be used in various applications. ##STR00001##

Covalent organic frameworks (COFs) usually crystallize as insoluble powders and their processing for suitable devices has been thought to be limited. Here, it is demonstrated that COFs can be mechanically pressed into shaped objects having anisotropic ordering with preferred orientation between the hk0 and 00/ crystallographic planes. Pellets prepared from bulk COF powders impregnated with LiClO.sub.4 displayed room temperature conductivity up to 0.26 mS cm.sup.−1 and stability up to 10.0 V (vs. Li.sup.+/Li.sup.0). This outcome portends use of COFs as solid-state electrolytes in batteries.

Covalent organic frameworks (COFs) usually crystallize as insoluble powders and their processing for suitable devices has been thought to be limited. Here, it is demonstrated that COFs can be mechanically pressed into shaped objects having anisotropic ordering with preferred orientation between the hk0 and 00/ crystallographic planes. Pellets prepared from bulk COF powders impregnated with LiClO.sub.4 displayed room temperature conductivity up to 0.26 mS cm.sup.−1 and stability up to 10.0 V (vs. Li.sup.+/Li.sup.0). This outcome portends use of COFs as solid-state electrolytes in batteries.

Disclosed herein are novel carborane hydroxamic acid matrix metalloproteinase (“MMP”) inhibitors and agents bearing borane-containing moieties and methods for their use in treating or preventing a disease, such as cancer and rheumatoid arthritis. In particular, disclosed herein are compounds of Formula (I) and pharmaceutically acceptable salt thereof: Formula (I) wherein the substituents are as described. ##STR00001##

Described herein are boron-containing precursor compounds, and compositions and methods comprising same, for forming boron-containing films. In one aspect, the film is deposited from at least one precursor having the following Formula I or II described herein. ##STR00001##

Described herein are boron-containing precursor compounds, and compositions and methods comprising same, for forming boron-containing films. In one aspect, the film is deposited from at least one precursor having the following Formula I or II described herein. ##STR00001##